logo
Share SHARE
FONT-SIZE Plus   Neg

Discovery Lab: USPTO Issues New Patent Supporting AEROSURF Development Program

Discovery Laboratories, Inc. (DSCO), a specialty biotechnology company, announced the United States Patent and Trademark Office, or USPTO, has issued a Notice of Allowance for a patent entitled "Capillary System With Fluidic Element." The license to this patent will provide the company with additional exclusivity regarding certain proprietary and technical aspects of its capillary aerosol generator technology, a key component of its AEROSURF program.

AEROSURF is an investigational combination drug-device product being developed to deliver Discovery Labs' KL4 surfactant in aerosolized form to premature infants with respiratory distress syndrome. The company plans to initiate its AEROSURF phase 2 clinical program in the fourth quarter of 2013.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
10 Worst Places To Raise A Family Whether you are a young couple building a nest or seasoned parents looking for a change of scenery, there are number of places around the country that should be avoided, according to personal finance website WalletHub. They looked at mainly five categories for... A passenger has filed a lawsuit against Canadian budget airline Sunwing Airlines for serving him cheap sparkling wine instead of champagne on board a flight, according to media reports. The Canadian passenger, Daniel MacDuff, reportedly boarded his Sunwing flight to Cuba in February, on a flight package that advertised a complimentary on-board champagne toast. Senate Health Committee Chairman Lamar Alexander, R-Tenn., and ranking member Patty Murray, D-Wash., announced Thursday that twenty-two other Senators are cosponsoring their bipartisan plan to provide short-term stability to Obamacare. The bipartisan bill includes a two-year extension of the cost-sharing...
comments powered by Disqus
Follow RTT